RxDoctor Payments Data

Bryan Baranowski

Clinical Cardiac Electrophysiology · Cleveland, OHNPI 1518137017

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,750 of the $30,951 with a category attached, or 63.8%. 7 manufacturers reported payments, led by Abbott at 58.2% of the total.

$30,951in general payments, 2019–2025

Across 57 payments — averaging $542.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$18K
  • Biosense Webster, Inc.$6K
  • Medical Device Business Services, Inc.$6K
  • Boston Scientific$417
  • Impulse Dynamics (USA) Inc.$149
  • Medtronic$146
  • plus $143 from 1 others
$72,152in research payments, 2019–2025

Across 12 payments — averaging $6012.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$72K

What the payments were for

  • Consulting fees$19,75064%
  • Speaking & faculty fees$8,08826%
  • Travel & lodging$5262%
  • Food & beverage$2,5878%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,951 in reported general payments places this provider in the 65th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$206,349
Medicare patients
973
Services billed
2,307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban589$699,077
XareltoRivaroxaban130$157,186
Dofetilide282$86,527
MultaqDronedarone Hcl15$29,947
Flecainide Acetate203$10,392
EntrestoSacubitril/Valsartan12$10,272
Metoprolol Succinate340$6,281
Norpace CrDisopyramide Phosphate14$5,886
Amiodarone Hcl166$3,255
Diltiazem 24hr Er (Cd)Diltiazem Hcl87$3,110
SotalolSotalol Hcl57$838
Tiadylt ErDiltiazem Hcl25$669
Diltiazem 24hr ErDiltiazem Hcl17$624
Losartan Potassium58$573
Metoprolol Tartrate102$446

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →